News & Updates
Filter by Specialty:
Another win for donanemab in TRAILBLAZER Alzheimer’s trial
In the phase III TRAILBLAZER-ALZ 2 study, donanemab significantly slowed clinical progression in individuals with early symptomatic Alzheimer’s disease* (AD) with amyloid and tau pathologies, demonstrating an important replication of the phase II findings.
Another win for donanemab in TRAILBLAZER Alzheimer’s trial
14 Aug 2023
Brain stimulation helps with Parkinson's disease-related walking problems
Delivering electrical stimulation over the cerebellum appears to improve gait disturbances in patients with Parkinson’s disease (PD) and help them walk better, as reported in a study from Japan.
Brain stimulation helps with Parkinson's disease-related walking problems
13 Aug 2023
Febuxostat vs benzbromarone: Which is more effective in CKD with hyperuricaemia, hypertension?
Treatment with either febuxostat or benzbromarone results in comparable outcomes among patients with stage G3 chronic kidney disease (CKD) with asymptomatic hyperuricaemia and hypertension, a study has shown.
Febuxostat vs benzbromarone: Which is more effective in CKD with hyperuricaemia, hypertension?
13 Aug 2023
Progesterone may raise chances of having a baby for couples with unexplained infertility
Couples with unexplained infertility who are seeking parenthood may benefit from progesterone treatment, which can increase the livebirth rates and decrease miscarriage rates by twofold, according to data from the PiNC* trial.
Progesterone may raise chances of having a baby for couples with unexplained infertility
13 Aug 2023
Camrelizumab plus chemo combo beneficial in Asian patients with advanced NSCLC
Adding camrelizumab to platinum-based chemotherapy in the neoadjuvant treatment setting appears to improve the rate of pathologic complete response (pCR) in Asian patients with stage IIIA or IIIB non–small cell lung cancer (NSCLC), with manageable toxicity, according to data from the phase II TD-FOREKNOW study.